Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis

British Journal of Nutrition

Volumn 104, Issue 4, 2010, Pages 513-519

  Lindsay, Ruth J ^a   Geier, Mark S ^b   Yazbeck, Roger ^c,d   Butler, Ross N ^e   Howarth, Gordon S ^a,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SOUTH AUSTRALIAN RESEARCH AND DEVELOPMENT INSTITUTE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

5 Fluorouracil; Chemotherapy; Emu oil; Mucositis; Rat model

Indexed keywords

ANTIINFLAMMATORY AGENT; EDIBLE OIL; EMU OIL; FLUOROURACIL; MYELOPEROXIDASE; SUCRASE; SUCROSE; UNCLASSIFIED DRUG; OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; ENTERITIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; ILEUM; INTESTINE CRYPT; INTESTINE VILLUS; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; QUANTITATIVE STUDY; RAT; SMALL INTESTINE; ANIMAL; BIRD; DRUG EFFECT; INTESTINE MUCOSA; LEUKOCYTE ACTIVATION; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT STRAIN;

AGOUTI; ANIMALIA; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DROMAIIDAE; FEMALE; FLUOROURACIL; ILEUM; INTESTINAL MUCOSA; MUCOSITIS; NEUTROPHIL ACTIVATION; NEUTROPHILS; OILS; RATS; RATS, INBRED STRAINS; SUCRASE;

EID: 77956209758     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451000084X     Document Type: Article

References (32)

1. Bowen JM, Gibson RJ, Cummins AG, et al. (2006) Intestinal mucositis: The role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 14, 713-731.
2. Gibson RJ, Bowen JM & Keefe DM (2005) Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats. Int J Cancer 116, 464-470.
3. Lalla RV & Peterson DE (2006) Treatment of mucositis, including new medications. Cancer J 12, 348-354.
4. Choi K, Lee SS, Oh SJ, et al. (2007) The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 26, 57-62.
5. Keefe DM (2004) Gastrointestinal mucositis: A new biological model. Support Care Cancer 12, 6-9.
6. Logan RM, Stringer AM, Bowen JM, et al. (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33, 448-460.
7. Keefe DM, Gibson RJ & Hauer-Jensen M (2004) Gastrointestinal mucositis. Semin Oncol Nurs 20, 38-47.
8. Gibson RJ, Keefe DMK, Clarke JM, et al. (2002) The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 50, 53-58.
9. von Bultzingslowen I, Brennan MT, Spijkervet FK, et al. (2006) Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 14, 519-527.
10. Cool JC, Dyer JL, Xian CJ, et al. (2005) Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracilinduced intestinal mucositis in rats. Growth Horm IGF Res 15, 72-82.
11. Howarth GS (2003) Insulin-like growth factor-I and the gastrointestinal system: Therapeutic indications and safety implications. J Nutr 133, 2109-2112.
12. Howarth GS, Francis GL, Cool JC, et al. (1996) Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 126, 2519-2530.
13. Clarke J, Butler RN, Howarth GS, et al. (2002) Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster. Oral Oncol 38, 478-485.
14. Gibson RJ, Stringer AM, Bowen JM, et al. (2007) Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats. Cancer Biol Ther 6, 541-547.
15. Whitehouse MW, Turner AG, Davis CK, et al. (1998) Emu oil(s): A source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology 6, 1-8.
16. Beckerbauer LM, Thiel-Cooper R, Ahn DU, et al. (2001) Influence of two dietary fats on the composition of emu oil and meat. Poult Sci 80, 187-194.
17. Yoganathan S, Nicolosi R, Wilson T, et al. (2003) Antagonism of croton oil inflammation by topical emu oil in CD-1 mice. Lipids 38, 603-607.
18. Lopez A, Sims DE, Ablett RF, et al. (1999) Effect of emu oil on auricular inflammation induced with croton oil in mice. Am J Vet Res 60, 1558-1561.
19. Snowden JM & Whitehouse MW (1997) Anti-inflammatory activity of emu oils in rats. Inflammopharmacology 5, 127-132.
20. Qiu XW, Wang JH, Fang XW, et al. (2005) Anti-inflammatory activity and healing-promoting effects of topical application of emu oil on wound in scalded rats. Di Yi Jun Yi Da Xue Xue Bao 25, 407-410.
21. Tomas FM, Murray AJ & Jones LM (1984) Modification of glucocorticoid-induced changes in myofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion of Ntau-methylhistidine. Br J Nutr 51, 323-337.
22. Pelton NS, Tivey DR, Howarth GS, et al. (2004) A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 39, 2.
23. Tooley KL, Howarth GS, Lymn KA, et al. (2009) Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis. Cancer Chemother Pharmacol 65, 913-921.
24. Cheng H & Bjerknes M (1982) Whole population cell kinetics of mouse duodenal, jejunal, ileal, and colonic epithelia as determined by radioautography and flow cytometry. Anat Rec. 203, 251-264.
25. Singh U & Jialal I (2004) Anti-inflammatory effects of alphatocopherol. Ann N Y Acad Sci 1031, 195-203.
26. Sylvester PW (2007) Vitamin E and apoptosis. Vitam Horm 76, 329-356.
27. Bennett DC, Code WE, Godin DV, et al. (2008) Comparison of the antioxidant properties of emu oil with other avian oils. Anim Prod Sci 48, 1345-1350.
28. Sonis ST (2004) Pathobiology of mucositis. Semin Oncol Nurs 20, 11-15.
29. Sonis ST, Elting LS, Keefe D, et al. (2004) Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995-2025.
30. Drozdowski L & Thomson ABR (2006) Intestinal mucosal adaptation. World J Gastroenterol 12, 4614-4627.
31. Haxhija EQ, Yang H, Spencer AU, et al. (2007) Intestinal epithelial cell proliferation is dependent on the site of massive small bowel resection. Paediatric Surg Int 23, 379-390.
32. Torres DM, Tooley KL, Butler RN, et al. (2008) Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis. Cancer Biol Ther 7, 295-302.